SourceBio International PLC Director/PDMR Shareholding (4879V)
13 Diciembre 2021 - 10:34AM
UK Regulatory
TIDMSBI
RNS Number : 4879V
SourceBio International PLC
13 December 2021
13 December 2021
SourceBio International plc
(" SourceBio", the "Company" or the "Group")
Director/PDMR Shareholding
SourceBio International plc ("the Company") has been notified
that on 10 December 2021, Harwood Capital LLP disposed of 4,154
ordinary shares of 0.15 pence each in the Company ("Ordinary
Shares") in aggregate. Christopher Mills, Non-Executive Director of
the Company is Chief Executive of Harwood Capital LLP.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Harwood Capital LLP as investment
manager
--------------------------------------- ------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------
a) Position/status Christopher Mills is a non-executive
director of the issuer and Chief
Executive of the investment manager
--------------------------------------- ------------------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------
a) Name SourceBio International Plc
--------------------------------------- ------------------------------------------
b) LEI 213800KY4C9WU7WBW518
--------------------------------------- ------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------------------
a) Description of the Ordinary shares of GBP0.0015 each
financial instrument,
type of instrument
Identification code GB00BKSB1674
b) Nature of the transaction Disposal of shares
--------------------------------------- ------------------------------------------
c) Price(s) and volume(s)
------------------ -------------------
Price(s) Volume(s)
------------------ -------------------
142.00p 4,154
------------------ -------------------
d) Aggregated information
Volume N/A - single transaction
Price
e) Date of the transaction 10 December 2021
f) Place of the transaction London Stock Exchange
--------------------------------------- ------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFVRFFLVLIL
(END) Dow Jones Newswires
December 13, 2021 11:34 ET (16:34 GMT)
Sourcebio (LSE:SBI)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Sourcebio (LSE:SBI)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
Real-Time news about Sourcebio International Plc (London Stock Exchange): 0 recent articles
Más de Sourcebio International Plc Artículos de Noticias